Status: Finalised
First registered on:
19/02/2021
Last updated on:
09/01/2023
1. Study identification
EU PAS Register NumberEUPAS39370
Official titleCoverage of COVID-19 vaccines in electronic healthcare databases: a protocol template from the ACCESS project
Study title acronymACCESS
Study typeObservational study
Brief description of the studyAs part of the preparedness activities for surveillance of COVID-19 vaccines, this template protocol provides a template for quickly developing a full study protocol to perform vaccine coverage studies through the secondary use of electronic healthcare data bases and/or immunization registers.
This protocol has been accepted by EMA as a deliverable of the framework contract No EMA/2018/28/PE.
Was this study requested by a regulator?Yes: EMA
Is the study required by a Risk Management Plan (RMP)?
Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsUMCU
Department/Research group
Organisation/affiliationUniversity Medical Center Utrecht
Details of (Primary) lead investigator
Title Professor
Last name Sturkenboom
First name Miriam
Is this study being carried out with the collaboration of a research network?
Yes
EU PE&PV research network
Other centres where this study is being conducted
Not applicable (single centre)
Countries in which this study is being conducted
International study
Italy
Netherlands
Spain
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed19/05/202019/05/2020
Start date of data collection19/05/202019/05/2020
Start date of data analysis
Date of interim report, if expected
Date of final study report15/12/202008/01/2021
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherEMA100
5. Contact details for enquiries
Scientific Enquiries
Title Professor
Last name Sturkenboom
First name Miriam
Address line 1Heidelberglaan 100
Address line 2
Address line 3
CityUtrecht
Postcode
CountryNetherlands
Phone number (incl. country code)31657831983
Alternative phone number
Fax number (incl. country code)
Public Enquiries
Title Professor
Last name Sturkenboom
First name Miriam
Address line 1Heidelberglaan 100
Address line 2
Address line 3
CityUtrecht
Postcode
CountryNetherlands
Phone number (incl. country code)31657831983
Alternative phone number
Fax number (incl. country code)
6. Study drug(s) information
Not applicable (disease/epidemiology study)
7. Medical conditions to be studied
Medical condition(s)No
8. Population under study
Age
Preterm newborns
Term newborns (0-27 days)
Infants and toddlers (28 days - 23 months)
Children (2 - 11 years)
Adolescents (12 - 17 years)
Adults (18 - 44 years)
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Sex
Male
Female
Other population
Renal impaired
Hepatic impaired
Immunocompromised
Pregnant women
9. Number of subjects
Estimated total number of subjects1000000
Additional information
Number of subjects depends on the study implementation. This EU PAS record includes a template protocol only.
10. Source of data
Is this study being carried out with an established data source?No
Sources of data
Choice of the data source depends on the study implementation. This EU PAS record includes a template protocol only.
11. Scope of the study
What is the scope of the study?
Drug utilisation study
Coverage evaluation
Primary scope : Coverage evaluation
12. Main objective(s)
What is the main objective of the study?
This is a template protocol to determine exposure and coverage to COVID-19 vaccines and to determine exposure and coverage to COVID-19 vaccines in specific subgroups that are targeted for vaccination.
Are there primary outcomes?No
Are there secondary outcomes?No
13. Study design
What is the design of the study?
Cohort study
14. Follow-up of patients
Will patients be followed up?Yes
Please describe duration of follow up
Several years
15. Data analysis plan
Please provide a brief summary of the analysis method
This protocol template includes a section describing descriptive analysis, measures of coverage, data integration, subroup analysis and sensitivity analysis as well as quality control.
16. ENCePP seal
Are you requesting the ENCePP seal for this study?
No
17. Full protocol
18. Study Results
Not submitted
Please list the 5 most relevant publications using data from your study
ReferenceLink to web-publication
None
19. Other relevant documents
Conflict(s) of interest of
investigator(s)Not submitted
Composition of Steering Group and
ObserversNot submitted
Other documents
DescriptionDocumentLatest version
Signed Code of
Conduct Checklist
Not submitted
Signed Code of Conduct Declaration
Not submitted
Signed Checklist for Study
Protocols
Not submitted
